BioRad Laboratories
Open
$277.12
Prev. Close
$277.11
High
$278.20
Low
$276.60
Market Snapshot
$7.42B
9.8
-64.90
$2.57B
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
emptyResult
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Recently from Cashu
VST BIO Corporation Secures $45 Million to Advance Stroke Therapeutics Development
VST BIO Corporation's Series A Financing Fuels Stroke Therapeutics Development VST BIO Corporation, a San Diego-based biotechnology firm specializing in stroke therapeutics, successfully secures $45 m…
Halia Therapeutics to Unveil Novel Inflammasome Inhibitors at BIO Investment & Growth Summit
Innovative Focus on Inflammasome Inhibition: Halia Therapeutics Sets the Stage at BIO Summit Halia Therapeutics prepares to captivate the biopharmaceutical community with its upcoming presentation at…
Halia Therapeutics to Present Novel Inflammation Treatments at BIO Investment & Growth Summit
Halia Therapeutics Set to Showcase Innovative Approaches to Inflammation at Upcoming Summit Halia Therapeutics, a promising player in the biopharmaceutical sector, plans to present its strategic visio…
Soligenix Showcases Innovative Therapies for Rare Diseases at BIO Investment & Growth Summit
Soligenix Advances New Therapies for Rare and Infectious Diseases Soligenix, Inc., a biopharmaceutical company focused on innovative treatments for rare diseases, announces that CEO Dr. Christopher J.…